89 related articles for article (PubMed ID: 34066083)
1. Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG.
Rasche M; Zimmermann M; Steidel E; Alonzo T; Aplenc R; Bourquin JP; Boztug H; Cooper T; Gamis AS; Gerbing RB; Janotova I; Klusmann JH; Lehrnbecher T; Mühlegger N; Neuhoff NV; Niktoreh N; Sramkova L; Stary J; Waack K; Walter C; Creutzig U; Dworzak M; Kaspers G; Kolb EA; Reinhardt D
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34066095
[TBL] [Abstract][Full Text] [Related]
2. The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
Mansur MB; Furness CL; Nakjang S; Enshaei A; Alpar D; Colman SM; Minto L; Irving J; Poole BV; Noronha EP; Savola S; Iqbal S; Gribben J; Pombo-de-Oliveira MS; Ford TM; Greaves MF; van Delft FW
Cancer Med; 2021 Jul; 10(14):4864-4873. PubMed ID: 34080325
[TBL] [Abstract][Full Text] [Related]
3. The Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia.
Gossai NP; Gordon PM
Front Pediatr; 2017; 5():90. PubMed ID: 28491865
[TBL] [Abstract][Full Text] [Related]
4. Unrelated cord blood transplantation for central nervous system relapse in high-risk childhood acute lymphoblastic leukemia.
Zheng C; Tang B; Tong J; Liu H; Geng L; Wang X; Ding K; Sun Z
Ann Hematol; 2013 Dec; 92(12):1665-73. PubMed ID: 23793915
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of the Central Nervous System-Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia.
Sági JC; Gézsi A; Egyed B; Jakab Z; Benedek N; Attarbaschi A; Köhrer S; Sipek J; Winkowska L; Zaliova M; Anastasopoulou S; Wolthers BO; Ranta S; Szalai C; Kovács GT; Semsei ÁF; Erdélyi DJ
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34066083
[TBL] [Abstract][Full Text] [Related]
6. Does minimal central nervous system involvement in childhood acute lymphoblastic leukemia increase the risk for central nervous system toxicity?
Anastasopoulou S; Harila-Saari A; Als-Nielsen B; Eriksson MA; Heyman M; Johannsdottir IM; Marquart HV; Niinimäki R; Pronk CJ; Schmiegelow K; Vaitkeviciene G; Thastrup M; Ranta S
Pediatr Blood Cancer; 2022 Jul; 69(7):e29745. PubMed ID: 35488712
[TBL] [Abstract][Full Text] [Related]
7. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.
Anastasopoulou S; Eriksson MA; Heyman M; Wang C; Niinimäki R; Mikkel S; Vaitkevičienė GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Harila-Saari A; Ranta S
Pediatr Blood Cancer; 2019 May; 66(5):e27594. PubMed ID: 30592147
[TBL] [Abstract][Full Text] [Related]
8. Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia.
Hattori S; Suda A; Kishida I; Miyauchi M; Shiraishi Y; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Moritani T; Taguri M; Hirayasu Y
BMC Psychiatry; 2018 Jul; 18(1):231. PubMed ID: 30016952
[TBL] [Abstract][Full Text] [Related]
9. Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes.
Anastasopoulou S; Nielsen RL; Als-Nielsen B; Banerjee J; Eriksson MA; Helenius M; Heyman MM; Johannsdottir IM; Jonsson OG; MacGregor S; Mateos MK; Mayoh C; Mikkel S; Myrberg IH; Niinimäki R; Schmiegelow K; Taskinen M; Vaitkeviciene G; Warnqvist A; Wolthers B; Harila-Saari A; Ranta S
Haematologica; 2022 Oct; 107(10):2318-2328. PubMed ID: 35354251
[TBL] [Abstract][Full Text] [Related]
10. GSTP1 and MDR1 genotypes and central nervous system relapse in childhood acute lymphoblastic leukemia.
Stanulla M; Schäffeler E; Arens S; Rathmann A; Schrauder A; Welte K; Eichelbaum M; Zanger UM; Schrappe M; Schwab M
Int J Hematol; 2005 Jan; 81(1):39-44. PubMed ID: 15717687
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000-2020).
Kim JA; Ceccarelli R; Lu CY
J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33806453
[TBL] [Abstract][Full Text] [Related]
12. Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go.
De Maria Marchiano R; Di Sante G; Piro G; Carbone C; Tortora G; Boldrini L; Pietragalla A; Daniele G; Tredicine M; Cesario A; Valentini V; Gallo D; Babini G; D'Oria M; Scambia G
J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33803592
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia.
Mateos MK; Marshall GM; Barbaro PM; Quinn MCJ; George C; Mayoh C; Sutton R; Revesz T; Giles JE; Barbaric D; Alvaro F; Mechinaud F; Catchpoole D; Lawson JA; Chenevix-Trench G; MacGregor S; Kotecha RS; Dalla-Pozza L; Trahair TN
Haematologica; 2022 Mar; 107(3):635-643. PubMed ID: 33567813
[TBL] [Abstract][Full Text] [Related]
14. Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin.
Aberuyi N; Rahgozar S; Pourabutaleb E; Ghaedi K
Curr Res Transl Med; 2021 Jan; 69(1):103269. PubMed ID: 33071214
[TBL] [Abstract][Full Text] [Related]
15. Association of three factors (ABCB1 gene expression, steroid response, early response at day + 8) on the response to induction in patients with acute lymphoblastic leukemia.
Ramos-Peñafiel C; Olarte-Carrillo I; Maldonado RC; de la Cruz Rosas A; Collazo-Jaloma J; Martínez-Tovar A
Ann Hematol; 2020 Nov; 99(11):2629-2637. PubMed ID: 32980890
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
